TY - JOUR AU - Yoneyama, Remi AU - Saji, Hisashi AU - Kato, Yasufumi AU - Kudo, Yujin AU - Shimada, Yoshihisa AU - Kimura, Masakazu AU - Hagiwara, Masaru AU - Kakihana, Masatoshi AU - Miyajima, Kuniharu AU - Kajiwara, Naohiro AU - Ohira, Tatsuo AU - Kato, Harubumi AU - Ikeda, Norihiko PY - 2019 TI - Clinicopathological characteristics and treatment strategies for young lung cancer patients JF - Annals of Translational Medicine; Vol 7, No 5 (March 13, 2019): Annals of Translational Medicine Y2 - 2019 KW - N2 - Background: The reported age-specific survival rates of lung cancer patients have been largely inconsistent. Management strategies for younger patients and treatment outcomes are not well characterized. Methods: Out of the 4,697 lung cancer patients with treatment history at Tokyo Medical University Hospital between January 2000 and December 2014, 266 patients were Results: The 1-, 3-, and 5-year survival rates in the ≤ 49 years age group were 82.9%, 64.6%, and 57.0%. Among surgical cases, the survival rate of patients in the ≤ 49 years age group was significantly better than that in the 50–69 and ≥ 70 years age groups (P=0.29 and P Conclusions: Despite the higher proportion of advanced disease, the postoperative survival rate of the younger was higher than that of the older. Aggressive multimodality treatments, including surgery, are more feasible and effective for younger patients as compared with that in older patients. UR - https://atm.amegroups.org/article/view/23903